-
Most Popular

Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.

The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Recent Biotech Stocks Articles
The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today
Vertex hopes Alpine's drug can be tested on other conditions beyond the one entering Phase 3 trial for a kidney disease.
Why Is Aptevo Therapeutics (APVO) Stock Down 56% Today?
Aptevo Therapeutics stock is falling on Thursday after the company priced a public offering for 3.4 million shares of APVO.
Why Is Rallybio (RLYB) Stock Up 93% Today?
Rallybio stock is rocketing higher on Thursday with heavy trading of RLYB shares after announcing a collaboration with Johnson & Johnson.
What Is Going on With Jaguar Health (JAGX) Stock Today?
A fifth reverse split may be coming to JAGX stock. Jaguar Health is seeking customers for its Crofelemer anti-diarrhea medicine.
ACRV Stock Jumps 55% as Acrivon Therapeutics Gets $130 Million Boost
Acrivon Therapeutics stock is up on Tuesday with heavy trading of ACRV shares alongside $130 million in new funding today.
Why Is Vivos Therapeutics (VVOS) Stock Up 16% Today?
Vivos Therapeutics stock is up on Tuesday as VVOS investors react to the company securing full Medicare reimbursement for its OSA device.
Why Is Vincerx Pharma (VINC) Stock Down 64% Today?
Vincerx Pharma stock is falling hard on Tuesday after the company failed to impress VINC shareholders with its latest clinical trial update.
Why Is MyMD Pharmaceuticals (MYMD) Stock Up 35% Today?
MyMD Pharmaceuticals stock is rising on Tuesday as MYMD investors react to a new amendment to a securities purchase agreement.
Why Is Biophytis (BPTS) Stock Up 43% Today?
Biophytis stock is up on Tuesday after the company provided BPTS shareholders with results for the fiscal full year of 2023!